If you or a loved one received a Boston Scientific Accolade, Proponent, Essentio, Altrua 2, Visionist, or Valitude pacemaker manufactured before September 2018, you may be entitled to significant financial compensation following one of the most serious cardiac device recalls in recent history. This Boston Scientific pacemaker defect damages calculator guide breaks down what your claim could be worth in 2026, using documented injury data, real medical cost benchmarks, and emerging settlement valuations from active litigation nationwide.
What Happened: The Boston Scientific Pacemaker Recall Explained
In December 2024, Boston Scientific issued an urgent field safety corrective action for its ACCOLADE family of pacemakers and CRT-P (cardiac resynchronization therapy pacemaker) devices. The company acknowledged reports of software failures, telemetry disablement, inaccurate battery diagnostics, and dangerous Safety Mode activation that could cause unintended device behavior or complete malfunction. In February 2025, the FDA upgraded the action to a Class I recall — the agency’s most serious designation, reserved for situations where use of the device may cause serious injury or death.
Affected models include the Accolade, Proponent, Essentio, Altrua 2, Visionist, and Valitude pacemakers, particularly those manufactured before September 2018. These devices were implanted in tens of thousands of patients across the United States who rely on them for continuous cardiac support. A pacemaker defect is not a minor inconvenience — for patients with heart block, sick sinus syndrome, or other arrhythmias, device failure can be immediately life-threatening.
In May 2026, the FDA issued an expanded advisory covering approximately 1.3 million defective Boston Scientific pacemakers — a significant escalation from earlier recall estimates. Critically, the May 2026 recall correction requires software upgrades to affected devices rather than physical removal and replacement, which has important implications for how injuries and damages are documented and valued. The scope of harm has grown substantially: as of March 18, 2026, four deaths and more than 2,557 serious injuries have been officially reported in connection with these defective devices. Lawsuits are currently consolidating nationwide, and early case valuations are establishing precedents that will shape settlements for years to come. Understanding how damages are calculated is critical before you accept any offer or waive any rights.
Documented Harm: Injuries, Deaths, and Device Failures by the Numbers
Before using any Boston Scientific pacemaker defect damages calculator, it is essential to understand the landscape of documented harm. The table below summarizes key data points drawn from FDA records, reported injury databases, and emerging litigation metrics as of 2026.
| Category | Documented Figure (2026) | Source / Context |
|---|---|---|
| Reported Deaths | 4 confirmed | FDA MAUDE database / Boston Scientific recall reports as of March 18, 2026 |
| Reported Serious Injuries | 2,557 confirmed | Boston Scientific adverse event reports as of March 18, 2026 |
| Total Devices Subject to Expanded Recall | Approximately 1.3 million | FDA advisory issued May 8, 2026 |
| Risk of Early Device Replacement | 7.6% for expanded recall devices | MassDevice, May 8, 2026 |
| Recall Remedy | Software upgrade (no physical removal required) | FDA recall correction, May 2026 |
| Early Compensation Offers Reported | As low as $2,500 per plaintiff | CallFob, August 2026 |
These numbers underscore why individual claim valuation matters so much. With 1.3 million affected devices and thousands of documented serious injuries, Boston Scientific faces enormous aggregate liability. Reports that the company has offered some plaintiffs as little as $2,500 in early-stage compensation suggest an aggressive strategy to limit payouts before litigation fully matures — making independent legal counsel and a thorough damages assessment essential for every claimant.
One figure that demands particular attention is the 7.6% risk of early device replacement associated with expanded recall pacemakers. For patients whose devices carry this elevated failure risk, the prospect of an unplanned surgical procedure — with all its attendant medical costs, recovery time, and physical and emotional toll — is a concrete and quantifiable harm that should be factored into any damages calculation. Additionally, affected devices may not achieve their projected longevity, meaning patients could face additional procedures and costs years sooner than originally anticipated.
How the Boston Scientific Pacemaker Defect Damages Calculator Works
A Boston Scientific pacemaker defect damages calculator is not a single formula. It is a structured methodology for identifying, documenting, and valuing every category of harm you have suffered — or may suffer in the future — as a result of receiving a defective pacemaker. Personal injury attorneys and medical device litigation specialists use this framework to build case valuations that hold up under defense scrutiny and judicial review.
The three core components of any medical device defect damages calculation are: economic damages, non-economic damages, and — where applicable — punitive damages. Each is calculated differently and requires a different type of supporting evidence.
Step 1 — Calculate Your Economic Damages (Hard Costs)
Economic damages are the measurable, documentable financial losses caused directly by your defective pacemaker. In Boston Scientific pacemaker defect cases, these typically include:
- Past medical expenses: All costs already incurred, including diagnostic imaging, hospitalization, cardiac monitoring, emergency care, physician fees, and any corrective procedures such as device reprogramming or replacement surgery. Pacemaker replacement surgeries alone routinely cost between $30,000 and $100,000 depending on the complexity of the procedure, the facility, and geographic region.
- Future medical expenses: This is especially significant given the 7.6% elevated risk of early device replacement documented for expanded recall pacemakers. If your device is statistically likely to fail ahead of schedule, you may require an unplanned replacement procedure. These projected future costs — including surgical fees, anesthesia, post-operative care, and follow-up monitoring — must be documented by a medical expert and calculated in present-value terms.
- Lost wages and income: If your pacemaker defect caused you to miss work during hospitalization or recovery, or if it has impaired your ability to work going forward, those income losses are compensable. This includes salary, self-employment income, bonuses, and benefits.
- Loss of earning capacity: If the injury has permanently reduced your ability to earn income at the same level as before, an economic expert can calculate the present value of that long-term loss.
- Out-of-pocket costs: Transportation to medical appointments, home health care, prescription medications, cardiac rehabilitation, and assistive devices all count toward your economic damages total.
Step 2 — Apply the Pain and Suffering Multiplier
Non-economic damages compensate you for harms that do not appear on a medical bill but are nonetheless real and significant. In medical device defect cases, these include:
- Physical pain and discomfort from the defect, associated symptoms, and any corrective procedures
- Emotional distress, anxiety, and fear of device failure
- Loss of enjoyment of life and inability to participate in activities you valued before
- Loss of consortium for your spouse or partner
- Psychological trauma, including post-traumatic stress following a cardiac event or emergency hospitalization
Attorneys typically calculate non-economic damages using a multiplier applied to your total economic damages. In serious injury cases involving cardiac devices, multipliers commonly range from 2x to 5x economic damages, depending on the severity and permanence of your injuries. In catastrophic cases — particularly those involving documented near-death experiences or permanent cardiac impairment — multipliers above 5x are not uncommon and can be justified with strong medical and expert testimony.
Step 3 — Add Punitive Damages Where Applicable
Punitive damages are not available in every case, but they are a legitimate and potentially significant component of Boston Scientific pacemaker defect claims where evidence supports them. Punitive damages are awarded not to compensate the plaintiff, but to punish the defendant for egregious conduct and deter similar behavior in the future.
In medical device defect litigation, punitive damages claims typically rest on evidence that the manufacturer knew about the defect and failed to act promptly, misrepresented the safety of the device to the FDA or to patients, prioritized commercial interests over patient safety, or delayed issuing warnings or initiating a recall. If internal communications, regulatory submissions, or quality control records demonstrate that Boston Scientific had knowledge of these software failures prior to the recall and delayed action, punitive damages could substantially increase the value of affected claims. Courts in some jurisdictions have awarded punitive damages at multiples of two to four times compensatory damages in similar medical device cases.
Wrongful Death Cases: Calculating Damages for Fatal Pacemaker Failures
With four confirmed deaths now linked to Boston Scientific pacemaker defects as of March 2026, wrongful death claims represent the most severe category of harm in this litigation. Families who have lost a loved one to a defective pacemaker may be entitled to a distinct and often substantial category of damages that goes beyond what an injured survivor can recover.
Wrongful death damages in medical device cases typically encompass the following:
- Medical expenses prior to death: All costs of emergency treatment, hospitalization, and end-of-life care caused by the device failure
- Funeral and burial expenses: Reasonable costs directly associated with the death
- Loss of financial support: The present value of the income the deceased would have earned and contributed to the household over their expected working lifetime
- Loss of services: The economic value of household contributions, childcare, and other services the deceased provided
- Loss of companionship and consortium: Compensation for the surviving spouse’s loss of the marital relationship, affection, and support
- Grief and mental anguish: Recoverable in most states for the emotional suffering experienced by surviving family members
- Punitive damages: Potentially available in wrongful death cases where the manufacturer’s conduct meets the applicable legal standard for egregious or reckless behavior
Wrongful death cases involving defective cardiac devices have historically produced some of the largest verdicts and settlements in medical device litigation. The combination of clear causation — a defective pacemaker in a patient who depended on it for survival — and documented corporate knowledge of the defect creates a compelling liability picture that often drives substantial settlement offers once litigation is well-developed.
Who Qualifies to Use This Boston Scientific Pacemaker Defect Damages Calculator
You may have a viable Boston Scientific pacemaker defect claim in 2026 if you meet one or more of the following criteria:
- You received a Boston Scientific Accolade, Proponent, Essentio, Altrua 2, Visionist, or Valitude pacemaker, particularly one manufactured before September 2018
- Your device has been identified as subject to the Class I recall or the expanded May 2026 FDA advisory covering 1.3 million devices
- You experienced device malfunction, Safety Mode activation, loss of telemetry, inaccurate battery readings, or any cardiac event potentially linked to your pacemaker
- You required emergency hospitalization, additional monitoring, device reprogramming, or pacemaker replacement surgery as a result of the defect
- You suffered physical injury, cardiac complications, or psychological harm attributable to your defective device
- You are the surviving family member of a patient who died as a result of a Boston Scientific pacemaker failure
Importantly, patients who have received the required software upgrade but have not yet experienced a serious adverse event may still have claims based on the documented 7.6% risk of early device replacement, the reduced projected longevity of their device, and the anxiety and medical monitoring burdens associated with carrying a known-defective implant. An experienced medical device attorney can evaluate whether your specific circumstances support a compensable claim even in the absence of acute physical injury.
Projected Settlement Ranges by Injury Severity (2026 Estimates)
Settlement values in medical device defect litigation vary enormously based on the nature and severity of individual injuries, the strength of causation evidence, the jurisdiction where the case is filed, and the overall trajectory of consolidated litigation. The ranges below reflect 2026 projections based on analogous medical device settlements, current injury data from the Boston Scientific recall, and early litigation signals. They are estimates intended to orient your expectations — not guarantees of any specific outcome.
Tier 1: Minor Injury or Single Additional Procedure
Patients who experienced device-related symptoms, required additional monitoring or a single non-surgical corrective procedure, and recovered without lasting harm may fall into this tier. Estimated settlement range: $25,000 to $100,000. Note that Boston Scientific has reportedly offered some early-stage plaintiffs as little as $2,500, which legal experts widely regard as far below the true value of even the most minor device-related claims. Accepting such an offer without independent legal counsel could result in a significant undervaluation of your case.
Tier 2: Premature Device Replacement (No Permanent Injury)
Patients who required unplanned pacemaker replacement surgery due to the defect — but who did not suffer permanent cardiac injury — represent a distinct and well-documented category of harm. Replacement surgery carries real risks, significant costs, and substantial recovery burdens. Given the documented 7.6% early replacement risk for expanded recall devices, this tier is likely to encompass a large number of claimants. Estimated settlement range: $100,000 to $300,000.
Tier 3: Severe Injury, Cardiac Complications, or Permanent Harm
Patients who suffered serious cardiac events, strokes, permanent arrhythmias, heart failure exacerbation, or other lasting physical consequences attributable to their defective pacemaker represent the most seriously injured survivors. These cases involve substantial economic damages — often including ongoing medical monitoring, future procedures, and lost earning capacity — as well as significant non-economic damages for pain, suffering, and diminished quality of life. Estimated settlement range: $300,000 to $1,000,000 or more, depending on the severity and permanence of the injury.
Tier 4: Wrongful Death
With four confirmed deaths linked to these defective devices as of March 2026, wrongful death claims occupy the highest tier of potential recovery. These cases involve the full range of wrongful death damages described above, including loss of lifetime earnings, loss of companionship, and potentially punitive damages. Estimated settlement range: $500,000 to $3,000,000 or more, depending on the age, income, and family circumstances of the deceased, as well as the strength of evidence linking the device failure to the death.
How Litigation Consolidation Affects Your Boston Scientific Pacemaker Defect Case in 2026
As of 2026, Boston Scientific pacemaker defect lawsuits are in active consolidation proceedings in federal court. When large numbers of cases involving the same defective product are filed across multiple jurisdictions, federal courts typically consolidate them into a Multidistrict Litigation (MDL) for coordinated pretrial proceedings. MDL consolidation serves important functions: it reduces duplicative discovery, creates consistent rulings on key legal questions, and — critically — positions the litigation for global settlement negotiations once bellwether trials have tested the strength of representative cases.
For individual plaintiffs, MDL consolidation has both advantages and implications to understand. On the positive side, your case benefits from the collective resources of a large plaintiff pool, shared expert witnesses, and the leverage that thousands of cases create at the settlement table. On the cautionary side, MDL proceedings move on their own timeline, and individual plaintiffs must ensure their specific injuries and damages are well-documented within the consolidated framework.
The May 2026 FDA advisory expanding the recall to 1.3 million devices significantly enlarges the potential plaintiff pool and may accelerate settlement discussions, as Boston Scientific’s total liability exposure becomes clearer. At the same time, the software-upgrade remedy — rather than physical device removal — may complicate damages arguments for plaintiffs who have not yet experienced acute adverse events, making careful individual case documentation all the more important.
Early bellwether trial results in MDL proceedings typically drive settlement ranges for the broader plaintiff population. Attorneys who have filed early and built strong individual case records are generally best positioned to maximize recovery when global settlement negotiations begin. If you have not yet retained counsel, the time to act is now — delay can affect both the strength of your evidence and your ability to meet applicable filing deadlines.
Frequently Asked Questions About Boston Scientific Pacemaker Defect Claims
What is the average settlement amount for a Boston Scientific pacemaker defect claim in 2026?
There is no single average settlement figure, because Boston Scientific pacemaker defect cases span an enormous range of injury severity, from patients who received a software upgrade without experiencing acute harm to families of patients who died from device failure. Based on analogous medical device litigation and the injury data available in 2026, credible estimates range from $25,000 for minor claims to $3,000,000 or more for wrongful death cases. Reports of Boston Scientific offering some early plaintiffs as little as $2,500 underscore the importance of independent legal valuation before accepting any offer. The litigation is still developing, and settlement values will become clearer as bellwether trials and global negotiations progress.
Which Boston Scientific pacemaker models are included in the Class I recall?
The original Class I recall and the expanded May 2026 FDA advisory cover the Accolade, Proponent, Essentio, Altrua 2, Visionist, and Valitude pacemaker families, with particular focus on devices manufactured before September 2018. The May 2026 expansion brought the total number of affected devices to approximately 1.3 million. If you are unsure whether your specific device is included, your cardiologist or device clinic can check the device serial number against the recall database, and an attorney can help you confirm your eligibility to file a claim.
Can I file a lawsuit if my Boston Scientific pacemaker was recalled but I have not been injured yet?
This is a nuanced question that depends on the law of your state and the specific facts of your situation. In general, personal injury claims require documented harm. However, patients with recalled devices who have not yet suffered acute injury may have claims based on the cost and burden of required medical monitoring, the documented 7.6% elevated risk of early device replacement, the reduced projected longevity of their device, and the emotional distress of carrying a known-defective cardiac implant. An experienced medical device attorney can evaluate your specific circumstances and advise you on whether a pre-injury monitoring claim or other theory of recovery is viable in your jurisdiction.
How long do I have to file a Boston Scientific pacemaker defect lawsuit?
The deadline to file a personal injury or wrongful death lawsuit — known as the statute of limitations — varies by state, typically ranging from two to four years from the date of injury or the date you knew or should have known that your injury was caused by the defective device. In some states, the discovery rule may toll (pause) the limitations period until you had reasonable notice of the connection between your pacemaker and your harm. Given that the expanded FDA advisory was issued in May 2026, some patients may be just beginning to understand the risk their device poses. Do not assume you have unlimited time — consult an attorney promptly to ensure your rights are protected.
Does the Class I recall classification automatically prove liability in my lawsuit?
The Class I recall designation is powerful evidence, but it does not automatically establish liability in a civil lawsuit. You must still prove that your specific device was defective, that the defect caused your specific injuries, and that you suffered compensable damages as a result. However, the FDA’s Class I classification — its most serious recall category — significantly supports your case by establishing that the agency determined the device posed a risk of serious injury or death. Combined with documented injury data, expert medical testimony, and evidence of what Boston Scientific knew and when, the recall creates a strong evidentiary foundation for liability claims. An experienced medical device litigator can advise you on how to build the strongest possible case based on your individual facts.
James Mitchell is a personal injury legal researcher with over a decade of experience analyzing settlement data and compensation trends across the United States. He has studied thousands of personal injury cases to help injury victims understand their legal rights and the potential value of their claims. James is not an attorney and the information he provides is for
educational purposes only.